David Daniel Ambrose’s MCR American Pharmaceuticals Launches New Website

Share Article

State-of-the-art site will allow Brooksville, Florida-based pharmaceuticals manufacturer to expand mission of selling directly to doctors and private healthcare providers, according to CEO David Daniel Ambrose.

David Daniel Ambrose is a true pro who understands this business inside and out and knows exactly how to communicate with his customers.

Pharmaceuticals distributor MCR American Pharmaceuticals announced today the launch of its new website, targeting doctors already distributing the company’s products – or those who would like to.

The new site at mcramerican.com coincides with MCR American Pharmaceutical’s recent announcement that it will begin distributing medicines and other products directly to doctors and private healthcare providers, Chief Executive Officer David Daniel Ambrose said in a press statement.

“This will help us respond to doctors’ needs much quicker,” David Daniel Ambrose said. “When a doctor visits the site and tells us he or she has a need for a product, thanks to this website, we will be able to get that product out the door that very same day.”

MCR American Pharmaceutical’s 20-product line includes the popular Maxiphen and Maxifed families of expectorants/decongestants. Main features of the new site include a thorough catalog of MCR American Pharmaceutical’s products and an ordering page, as well as an interactive feature allowing doctors to submit questions or request further information about the company and its products.

The site will be updated regularly as new products become available, David Daniel Ambrose said.

“We expect the site to be very active,” noted web developer Daniel Dean. “An engaging, customer-friendly site is exactly what David Daniel Ambrose wanted. He’s a true pro who understands this business inside and out and knows exactly how to communicate with his customers.”

The chief executive brings more than 15 years of industry experience MCR American Pharmaceuticals, which he bought in 1999 just two years after joining its sales team. He is the founder of pharmaceuticals providers TG United Inc. and Ambi Pharmaceuticals, both of which he sold in 2008 to Neural High-Tech Pharmaceuticals, shortly before taking over as Neural High-Tech’s chairman and CEO.

David Daniel Ambrose received a bachelor’s degree in finance from West Virginia University in 1990.

The launch of mcramerican.com coincides with the launch of a new website for TG United Inc. at tgunited.com. That site is designed to inform current and future customers about TG United’s products and latest news, and also offers a comprehensive products list.

“This is such an exciting time for our companies,” David Daniel Ambrose said. “Growth is always exciting, and the launch of our new websites is the perfect illustration of our ongoing mission to expand and provide new and better services to our clients and industry partners.

“The launch of the new MCR American website is especially thrilling for us, since it embodies our new business model of skipping the pharmacies and putting our products directly into doctors’ hands,” David Daniel Ambrose added. “Selling products directly to doctors through the new site will ensure our top-line products get into patients’ hands quicker, and really help build our brand.”

About David Daniel Ambrose
David Daniel Ambrose is a pharmaceutical company chief executive with more than 15 years of industry experience. David is the CEO of MCR American Pharmaceuticals and TG United Inc, as well as parent company Neural High-Tech Pharmaceuticals, all based on Brooksville, Florida. David Daniel Ambrose received a bachelor’s degree in finance from West Virginia University in 1990 and lives in Brooksville with his wife of 18 years, Amanda, and their three children.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Dayna Malek